Regeneron Pharmaceuticals reported $450M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.06B 110M
Agenus AGEN:US $ 18.95M 3.02M
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
Alimera Sciences ALIM:US $ 10.09M 273K
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Amgen AMGN:US $ 1.23B 197M
Astellas Pharma 4503:JP 142.42B 6.51B
AstraZeneca AZN:LN 3.06B 1.03B
Biogen BIIB:US $ 634.9M 153M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Eli Lilly And LLY:US $ 1.56B 34.1M
Esperion Therapeutics ESPR:US $ 30.38M 5.29M
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Kyowa Hakko Kirin 4151:JP 33.61B 5.38B
Merk MRK:US $ 2.3B 518M
Moderna Inc MRNA:US 268M 67M
Novartis NVS:US 3.5B 486M
Novartis NOVN:VX 3.5B 486M
Ophthotech OPHT:US $ 12.11M 4.11M
Opthea Ltd OPT:AU 7.64M 487.97K
Puma Biotechnology PBYI:US $ 20.4M 2.06M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Teva Pharmaceutical TEVA:IT 819M 39M
Ultragenyx Pharmaceutical RARE:US $ 67.31M 7.88M
United Therapeutics UTHR:US $ 79M 47.9M
Vertex Pharmaceuticals VRTX:US $ 215.2M 39.96M
YTE INCY:US $ 209.58M 16.62M